Synageva BioPharma names new board member

Synageva BioPharma has appointed Mark Goldberg, senior vice president of clinical research at Genzyme and a medical oncologist and hematologist, to the company's board of directors. Dr Goldberg first joined Genzyme in 1996 as medical director for oncology and following several promotions, has held his current position of senior vice president of clinical research since 2000. Prior to working at Genzyme, Dr Goldberg was a full-time staff physician at Brigham and Women's Hospital and Dana Farber Cancer Institute, where he still holds appointments. Sanj Patel, president and CEO of Synageva, said: "Having worked very closely with Dr Goldberg for... [read full story]